Erratum: Efficacy and Safety of Oral Diclofenac Sustained release Versus Transdermal Diclofenac Patch in Chronic Musculoskeletal Pain: A Randomized, Open Label Trial
1. Shinde VA1★, Kalikar M1, Jagtap S1, Dakhale GN1, Bankar M1, Bajait CS1, et al. Efficacy1, safety of oral diclofenac versus transdermal diclofenac patch in1★ Corresponding author
- 1chronic musculoskeletal pain: A randomized, open‑label trial. J Pharmacol Pharmacother 2017;8:166-71.
CORRESPONDENCE
1. Shinde VA
chronic musculoskeletal pain: A randomized, open‑label trial. J Pharmacol Pharmacother 2017;8:166-71.
Volume 9, Issue 4 · pp. 200–200 · PUBLISHED 2018 · DOI: 10.4103/0976-500X.251391
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
In the article titled “Efficacy and Safety of Oral Diclofenac Sustained release Versus Transdermal Diclofenac Patch in Chronic Musculoskeletal Pain: A Randomized, Open Label Trial”, published on pages 166-171, Issue 4, Volume 8 of Journal of Pharmacology and Pharmacotherapeutics[1], the affiliation of “Viraj Ashok Shinde” is written incorrectly as “Department of Pharmacology, Government Medical College, Nagpur, Maharashtra, India” instead of “Department of Pharmacology, Dr. V.M. Government Medical College, Solapur, Maharashtra, India”.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
VA, S., M, K., S, J., GN, D., M, B., CS, B., Efficacy, E. A., & in, S. O. O. D. V. T. D. P. (2018). Erratum: Efficacy and Safety of Oral Diclofenac Sustained release Versus Transdermal Diclofenac Patch in Chronic Musculoskeletal Pain: A Randomized, Open Label Trial. Journal of Pharmacology and Pharmacotherapeutics, 9(4), 200–200. https://doi.org/10.4103/0976-500X.251391
